Additional file 4: Figure S2. of ID1 promotes hepatocellular carcinoma proliferation and confers chemoresistance to oxaliplatin by activating pentose phosphate pathway

ID1/G6PD signaling predicts unfavourable clinical prognosis in HCC patients. Differences in overall survival according to the expression of ID1 (A), G6PD (B) and their combination (C) were found to be statistically significant in HCC TCGA database. (PDF 1126 kb)